This week, investors will be looking to several key regional data points, including the latest inflation data out of the U.K.

U.S.-traded shares of European vaccine makers Bavarian Nordic and AstraZeneca fell 14% and 2.8%, respectively. The fear also hit obesity and diabetes drugmakers: Ozempic-maker Novo Nordisk and ...

Liberia is set to receive 10,000 doses of the mpox vaccine to help protect the country from the outbreak which has claimed at ...

Discover more on Bavarian Nordic's vaccine sales decline, diversification strategy, and strong Travel Health segment, ...

Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.

Bavarian Nordic A/S ( (BVNRY) ) has released its Q3 earnings. Here is a breakdown of the information Bavarian Nordic A/S presented to its ...

Current health news highlights include calls to reduce mpox test prices, CDC confirming Oregon's bird flu case, Eyenovia's ...

Health-care companies fell sharply as the selection of Robert F. Kennedy Jr. as Donald Trump's nominee to head the Department of Health and Human Services weighed on vaccine makers. Shares of Pfizer, ...

Fear is spreading across healthcare stocks after news emerged that President-elect Donald Trump will nominate vaccine skeptic ...

Europe's STOXX 600 fell on Friday, dragged by technology and healthcare stocks, keeping the index on track for its fourth ...

The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna were roughly 9% ...

Bavarian Nordic A/S posted the largest decline among large stocks during the session, tumbling 17.4%, followed by Gubra A/S shares, which tumbled 11.1%. Shares of Swedish Orphan Biovitrum AB plunged ...